A cyclin-dependent kinase inhibitor, dinaciclib in preclinical treatment models of thyroid cancer

por Lin, Shu-Fu, Lin, Jen-Der, Hsueh, Chuen, Chou, Ting-Chao, Wong, Richard J.
Publicado 2017

Effects of roniciclib in preclinical models of anaplastic thyroid cancer

por Lin, Shu-Fu, Lin, Jen-Der, Hsueh, Chuen, Chou, Ting-Chao, Wong, Richard J.
Publicado 2017

Activity of roniciclib in medullary thyroid cancer

por Lin, Shu-Fu, Lin, Jen-Der, Hsueh, Chuen, Chou, Ting-Chao, Wong, Richard J.
Publicado 2018

Utility of a Histone Deacetylase Inhibitor (PXD101) for Thyroid Cancer Treatment

por Lin, Shu-Fu, Lin, Jen-Der, Chou, Ting-Chao, Huang, Yu-Yao, Wong, Richard J.
Publicado 2013

Therapeutic inhibition of polo‐like kinases in anaplastic thyroid cancer

por Lin, Shu‐Fu, Yeh, Chun‐Nan, Huang, Yu‐Tung, Chou, Ting‐Chao, Wong, Richard J.
Publicado 2021

Utility of a PI3K/mTOR Inhibitor (NVP-BEZ235) for Thyroid Cancer Therapy

por Lin, Shu-Fu, Huang, Yu-Yao, Lin, Jen-Der, Chou, Ting-Chao, Hsueh, Chuen, Wong, Richard J.
Publicado 2012

Efficacy and Biomarker Analysis of Adavosertib in Differentiated Thyroid Cancer

por Lu, Yu-Ling, Wu, Ming-Hsien, Lee, Yi-Yin, Chou, Ting-Chao, Wong, Richard J., Lin, Shu-Fu
Publicado 2021

Efficacy of an HSP90 inhibitor, ganetespib, in preclinical thyroid cancer models

por Lin, Shu-Fu, Lin, Jen-Der, Hsueh, Chuen, Chou, Ting-Chao, Yeh, Chun-Nan, Chen, Ming-Huang, Wong, Richard J.
Publicado 2017